This stock looks to be very under valued right now. Seems to be flying under the radar... Phase 2 data from last year for TG-1101 was very good! Phase 3 data of TG-1101 and IMBRUVICA (Genuine trial) for Chronic Lymphocytic Leukemia (CLL) is coming soon
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.